These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24162705)

  • 1. The authors reply.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Nov; 41(11):e397-8. PubMed ID: 24162705
    [No Abstract]   [Full Text] [Related]  

  • 2. Selenium for sepsis: what have we learned so far?
    Huang TS; Shyu YC; Yuan SS; Chen PJ
    Crit Care Med; 2013 Nov; 41(11):e396. PubMed ID: 24162703
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5 H2O)·Na2SeO3 pharmacological effect?*.
    Forceville X
    Crit Care Med; 2013 Jun; 41(6):1591-2. PubMed ID: 23685589
    [No Abstract]   [Full Text] [Related]  

  • 4. Proton pump inhibitors in patients with end-stage liver disease.
    Al-Khafaji A; Garavaglia JM
    Crit Care Med; 2013 Nov; 41(11):e396-7. PubMed ID: 24162704
    [No Abstract]   [Full Text] [Related]  

  • 5. Selenium in intensive care: probably not a magic bullet but an important adjuvant therapy.
    Berger MM; Shenkin A
    Crit Care Med; 2007 Jan; 35(1):306-7. PubMed ID: 17197777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical data on the use of selenase in sepsis].
    Lehmann Ch
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S411-3. PubMed ID: 19998233
    [No Abstract]   [Full Text] [Related]  

  • 7. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome.
    Berger MM; Chioléro RL
    Crit Care Med; 2007 Sep; 35(9 Suppl):S584-90. PubMed ID: 17713413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaconutrition with selenium in critically ill patients: what do we know?
    Manzanares W; Langlois PL; Heyland DK
    Nutr Clin Pract; 2015 Feb; 30(1):34-43. PubMed ID: 25524883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selenium administration in patients with sepsis syndrome. A prospective randomized study].
    Zimmermann T; Albrecht S; Kühne H; Vogelsang U; Grützmann R; Kopprasch S
    Med Klin (Munich); 1997 Sep; 92 Suppl 3():3-4. PubMed ID: 9417494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selenium in critically ill patients with systemic inflammatory response].
    Manzanares Castro W
    Nutr Hosp; 2007; 22(3):295-306. PubMed ID: 17612371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium replacement in severe systemic inflammatory response syndrome.
    Opal SM
    Crit Care Med; 1999 Sep; 27(9):2042-3. PubMed ID: 10507647
    [No Abstract]   [Full Text] [Related]  

  • 12. Selenium supplementation in the critically ill: posology and pharmacokinetics.
    Manzanares W; Hardy G
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):273-80. PubMed ID: 19333120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma selenium is associated with better outcomes in children with systemic inflammation.
    Leite HP; Nogueira PC; Iglesias SB; de Oliveira SV; Sarni RO
    Nutrition; 2015 Mar; 31(3):485-90. PubMed ID: 25701339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaconutrition with parenteral selenium in sepsis].
    Langlois PL; de Oliveira Figliolino LF; Hardy G; Manzanares W
    Med Intensiva; 2014 Apr; 38(3):173-80. PubMed ID: 24021703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium.
    Brodska H; Valenta J; Malickova K; Kohout P; Kazda A; Drabek T
    J Trace Elem Med Biol; 2015; 31():25-32. PubMed ID: 26004888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium supplementation in the critically ill.
    Hardy G; Hardy I; Manzanares W
    Nutr Clin Pract; 2012 Feb; 27(1):21-33. PubMed ID: 22307489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein C--a new opening in the treatment of sepsis syndrome].
    Petäjä J; Heikinheimo M
    Duodecim; 2002; 118(12):1217-9. PubMed ID: 12239812
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystalloid fluid therapy: is the balance tipping towards balanced solutions?
    Young PJ; Joannidis M
    Intensive Care Med; 2014 Dec; 40(12):1966-8. PubMed ID: 25385475
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondria-Targeted Antioxidants and Uncouplers of Oxidative Phosphorylation in Treatment of the Systemic Inflammatory Response Syndrome (SIRS).
    Zakharova VV; Pletjushkina OY; Zinovkin RA; Popova EN; Chernyak BV
    J Cell Physiol; 2017 May; 232(5):904-912. PubMed ID: 27684052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human activated protein C for severe sepsis.
    O'Connor PE
    N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.